Should You Buy Teva Pharmaceutical Industries Ltd (TEVA) Stock on Wednesday?

The market has been high on Teva Pharmaceutical Industries Ltd (TEVA) stock recently. TEVA gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Teva Pharmaceutical Industries Ltd has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on TEVA!

See Full TEVA Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With TEVA Stock Today?

Teva Pharmaceutical Industries Ltd (TEVA) stock has gained 8.3% while the S&P 500 is lower by -0.09% as of 10:01 AM on Wednesday, Jul 28. TEVA is up $0.74 from the previous closing price of $8.92 on volume of 7,279,500 shares. Over the past year the S&P 500 is up 35.76% while TEVA is lower by -16.36%. TEVA lost -$3.63 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for Teva Pharmaceutical Industries Ltd click here.

More About Teva Pharmaceutical Industries Ltd

Headquartered in Israel, Teva Pharmaceutical is the largest generic drug manufacturer in the world. The company was formed in 1901 and has a portfolio of more than 3,500 medicines--roughly 1 out of 9 generic prescriptions in the U.S. is filled with a Teva product. The company also develops branded pharmaceuticals in the central nervous system, oncology, and respiratory categories. Teva's generic drug sales represent slightly over half of total revenue, with branded drug and distribution revenue making up the balance. Teva is an aggressive filer to bring generic drugs to market when brand patents expire and has the most generic products pending Food and Drug Administration approval. Click Here to get the full Stock Report for Teva Pharmaceutical Industries Ltd stock.